NPCE insider transactions
Neuropace Inc. (NPCE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for NPCE
- SEC Form 4 filed by Morrell Martha4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Geiger Uri4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Lacob Joseph4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Kumar Rakhi4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Fischer Frank M4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha sold $399,250 worth of shares (25,000 units at $15.97) and covered exercise/tax liability with 1,340 shares, decreasing direct ownership by 35% to 48,624 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF EXECUTIVE OFFICER Becker Joel covered exercise/tax liability with 5,023 shares, decreasing direct ownership by 5% to 96,937 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF EXECUTIVE OFFICER Becker Joel covered exercise/tax liability with 1,126 shares, decreasing direct ownership by 1% to 101,960 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 358 shares, decreasing direct ownership by 0.48% to 74,964 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 3,412 shares, decreasing direct ownership by 4% to 75,322 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Lacob Joseph was granted 678 shares, increasing direct ownership by 5% to 13,889 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Kumar Rakhi was granted 904 shares, increasing direct ownership by 5% to 18,007 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Fischer Frank M was granted 1,431 shares, increasing direct ownership by 0.24% to 593,351 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Geiger Uri was granted 715 shares, increasing direct ownership by 5% to 13,945 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 1,338 shares, decreasing direct ownership by 2% to 78,734 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF EXECUTIVE OFFICER Becker Joel covered exercise/tax liability with 1,126 shares, decreasing direct ownership by 1% to 103,086 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 357 shares, decreasing direct ownership by 0.44% to 80,072 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 3,051 shares, decreasing direct ownership by 4% to 80,429 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Geiger Uri was granted 1,194 shares, increasing direct ownership by 10% to 13,230 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Fischer Frank M was granted 2,389 shares, increasing direct ownership by 0.41% to 591,920 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Kumar Rakhi was granted 1,509 shares, increasing direct ownership by 10% to 17,103 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Lacob Joseph was granted 1,131 shares, increasing direct ownership by 9% to 13,211 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 1,337 shares, decreasing direct ownership by 2% to 83,480 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 357 shares, decreasing direct ownership by 0.42% to 84,817 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF EXECUTIVE OFFICER Becker Joel covered exercise/tax liability with 1,126 shares, decreasing direct ownership by 1% to 104,212 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 3,052 shares, decreasing direct ownership by 3% to 85,174 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Chief Financial Officer Williams Patrick F. was granted 51,850 shares (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 3 filed by new insider Williams Patrick F.3 - NeuroPace Inc (0001528287) (Issuer)
- Director Geiger Uri was granted 12,036 shares (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Lacob Joseph was granted 11,696 shares, increasing direct ownership by 3,046% to 12,080 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Kumar Rakhi was granted 15,594 shares (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Director Fischer Frank M was granted 23,874 shares, increasing direct ownership by 4% to 589,531 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Director Ryan Renee4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Director Lacob Joseph4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Director Kumar Rakhi4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Director Geiger Uri4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Director Huennekens R Scott4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Director Fischer Frank M4 - NeuroPace Inc (0001528287) (Issuer)
- SEC Form 4 filed by Director Andrade Lisa4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF FINANCIAL OFFICER Kuhn Rebecca covered exercise/tax liability with 1,337 shares, decreasing direct ownership by 1% to 131,613 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 1,338 shares, decreasing direct ownership by 2% to 85,943 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF EXECUTIVE OFFICER Becker Joel covered exercise/tax liability with 1,126 shares, decreasing direct ownership by 1% to 105,338 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF FINANCIAL OFFICER Kuhn Rebecca covered exercise/tax liability with 357 shares, decreasing direct ownership by 0.27% to 132,950 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 357 shares, decreasing direct ownership by 0.41% to 87,281 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF FINANCIAL OFFICER Kuhn Rebecca covered exercise/tax liability with 3,051 shares, decreasing direct ownership by 2% to 133,307 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 3,051 shares, decreasing direct ownership by 3% to 87,638 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Large owner Orbimed Advisors Llc sold $2,665,333 worth of shares (168,136 units at $15.85) (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF FINANCIAL OFFICER Kuhn Rebecca covered exercise/tax liability with 237 shares, decreasing direct ownership by 0.17% to 136,358 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 237 shares, decreasing direct ownership by 0.26% to 90,689 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha was granted 11,700 shares, increasing direct ownership by 15% to 90,926 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF FINANCIAL OFFICER Kuhn Rebecca was granted 11,700 shares, increasing direct ownership by 9% to 136,595 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF EXECUTIVE OFFICER Becker Joel covered exercise/tax liability with 4,506 shares and was granted 58,500 shares, increasing direct ownership by 103% to 106,464 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 1,337 shares, decreasing direct ownership by 2% to 79,226 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF FINANCIAL OFFICER Kuhn Rebecca covered exercise/tax liability with 1,337 shares, decreasing direct ownership by 1% to 124,895 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF FINANCIAL OFFICER Kuhn Rebecca covered exercise/tax liability with 1,430 shares, decreasing direct ownership by 1% to 126,232 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha covered exercise/tax liability with 1,430 shares, decreasing direct ownership by 2% to 80,563 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha sold $1,074,844 worth of shares (78,334 units at $13.72), decreasing direct ownership by 49% to 81,993 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha exercised 50,000 shares at a strike of $0.03, increasing direct ownership by 45% to 160,327 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- CHIEF MEDICAL OFFICER Morrell Martha exercised 52,618 shares at a strike of $0.03, exercised 192 shares at a strike of $0.03 and covered exercise/tax liability with 43,092 shares, increasing direct ownership by 11% to 96,480 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)
- Chief Financial Officer Kuhn Rebecca covered exercise/tax liability with 37,480 shares, decreasing direct ownership by 16% to 127,662 units (SEC Form 4)4 - NeuroPace Inc (0001528287) (Issuer)